Clinical Outcomes of COVID‑19 Patients with Rheumatic and Musculoskeletal Diseases: A Single Centre Cohort Study

Carolina Mazeda; Anabela Barcelos

doi:10.20344/amp.19062

Clinical Outcomes of COVID‑19 Patients with Rheumatic and Musculoskeletal Diseases: A Single Centre Cohort Study

Authors

Carolina Mazeda Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz. Health Alliance. Aveiro. https://orcid.org/0000-0002-9200-5022
Anabela Barcelos Rheumatology Department. Centro Hospitalar do Baixo Vouga. Aveiro; Centro Académico Clínico Egas Moniz. Health Alliance. Aveiro; Comprehensive Health Research Center. Universidade NOVA de Lisboa. Lisboa. https://orcid.org/0000-0002-4116-8964

DOI:

https://doi.org/10.20344/amp.19062

Keywords:

COVID-19, Hospitalization; Musculoskeletal Diseases, Rheumatic Diseases, SARS-CoV-2

Abstract

N/a.

Downloads

Download data is not yet available.

References

World Health Organization. Coronavirus (COVID-19) events as they happen. Geneva: WHO. [cited 2022 Sep 01]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-asthey-happen.

Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H, et al. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Clin Rheumatol. 2022;41:2213-23. DOI: https://doi.org/10.1007/s10067-022-06087-1

Xu C, Yi Z, Cai R, Chen R, Thong BY, Mu R. Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data. Autoimmun Rev. 2021;20:102778. DOI: https://doi.org/10.1016/j.autrev.2021.102778

Landewé RB, Kroon FP, Alunno A, Najm A, Bijlsma JW, Burmester GR, et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann Rheum Dis. 2022;81:1628-39. DOI: https://doi.org/10.1136/annrheumdis-2021-222006

Cruz-Machado AR, Barreira SC, Bandeira M, Veldhoen M, Gomes A, Serrano M, et al. Risk factors for infection, predictors of severe disease, and antibody response to COVID-19 in patients with inflammatory rheumatic diseases in Portugal - a multicenter, nationwide study. Front Med. 2022;9:901817. DOI: https://doi.org/10.3389/fmed.2022.901817

Downloads

Published

2023-02-01

How to Cite

Mazeda C, Barcelos A. Clinical Outcomes of COVID‑19 Patients with Rheumatic and Musculoskeletal Diseases: A Single Centre Cohort Study. Acta Med Port [Internet]. 2023 Feb. 1 [cited 2024 Nov. 22];36(2):140-1. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19062

Download Citation

Issue

Vol. 36 No. 2 (2023): February

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.